COPA SYNDROME

Clinical trials for COPA SYNDROME explained in plain language.

Never miss a new study

Get alerted when new COPA SYNDROME trials appear

Sign up with your email to follow new studies for COPA SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New pill aims to tame rare immune diseases

Disease control Ongoing

This early-stage trial tests an experimental drug called BI 3000202 in 16 adults with rare type 1 interferonopathies, such as Aicardi-Goutières syndrome. Participants take a low dose for 4 weeks, then a higher dose for 36 weeks. The main goal is to see if the drug is safe and how…

Matched conditions: COPA SYNDROME

Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC

COPA SYNDROME

Get alerted when new COPA SYNDROME trials appear

New pill aims to tame rare immune diseases